Why Africa. Why Lesotho.

Climate, cost, regulation and trade access: the structural advantages of growing at altitude in the Kingdom of Lesotho.

Africa offers a unique convergence of factors for medicinal cannabis production that no other region can match.

2,500+Hours of sunshine a year

1,500 mAbove sea level

LowestProduction costs on earth

Climate

Lesotho’s high-altitude subtropical climate delivers exceptional light intensity, low humidity and natural pest resistance. These are ideal growing conditions that dramatically reduce input costs versus indoor European or Canadian operations. Natural UV exposure at altitude enhances terpene and cannabinoid production.

Cost

Labour, land and energy costs in Lesotho are a fraction of European equivalents. A fully operational cultivation site in Lesotho costs less to build and run than a single indoor grow room in Germany.

Regulatory First Mover

Lesotho was the first African country to grant licences for medicinal cannabis cultivation and export, establishing a clear legal framework now followed by South Africa, Zimbabwe, Malawi and others.

EU Trade Access

Lesotho-produced medicinal cannabis can be exported to EU markets under the same GACP frameworks that govern pharmaceutical raw material supply chains. Our GACP certification is in place, and we are targeting EU-GMP certification by the end of 2026 with the completion of our own processing facility.

Watch

The Kingdom in the Sky

Why Lesotho · Watch the film

Video loads from YouTube (privacy-enhanced mode) only when you press play.

2,500+ hours of sunshine a year. 1,500 metres above sea level. The lowest production costs on earth. This is why we grow in Lesotho.

FAQs

Frequently asked questions

Everything you need to know about Frontier Botanics, our operations, and the investment opportunity. Still have questions? Our team is happy to walk you through the detail.

Get In Touch

Is medical cannabis legal in the UK?

Yes. Medical cannabis has been legal in the UK since November 2018 following changes introduced after high-profile cases like that of Alfie Dingley. However, access is tightly regulated and prescriptions are typically issued by specialist doctors. Frontier Botanics operates fully within UK and international legal frameworks to ensure compliance at every stage of production and distribution.

Why is cultivation based in Lesotho?

Lesotho was the first African nation to legalise medical cannabis cultivation and export, offering a stable regulatory environment, favourable climate, and cost-efficient production conditions. This allows Frontier Botanics to produce high-quality, pharmaceutical-grade cannabis at scale while maintaining competitive pricing for international markets.

What makes Frontier Botanics different from other medical cannabis companies?

Frontier Botanics focuses on vertically integrated operations—from cultivation in Lesotho to distribution in the UK—ensuring full control over quality, compliance, and supply chain efficiency. The company combines pharmaceutical standards with scalable infrastructure, positioning itself to meet growing demand in regulated global markets.

What is the current investment opportunity?

Frontier Botanics is currently raising capital to expand cultivation capacity, enhance processing facilities, and secure additional distribution partnerships. The funding round is designed to accelerate growth, increase production output, and strengthen the company’s position within the rapidly expanding global medical cannabis market.

What is the market potential for medical cannabis?

The global medical cannabis market is projected to grow significantly over the coming decade, driven by increasing legalisation, patient demand, and clinical research. Countries across Europe—including the UK—are gradually expanding access, creating a strong long-term growth opportunity for early-stage, compliant operators like Frontier Botanics.

Invest With Us

Ready to explore the opportunity?

Request the investor information pack or speak directly with the team. Available to eligible High Net Worth and Sophisticated Investors.

Request Information +44 (0) 203 996 1741